Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigal Gery

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Blood|June 30, 2005
Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemiaSigal Gery, Adrian F Gombart, William S Yi, et al.
Blood|August 17, 2004
Retinoic acid regulates C/EBP homologous protein expression (CHOP), which negatively regulates myeloid target genesSigal Gery, Dorothy J Park, Peter T Vuong, et al.
British Journal of Haematology|April 18, 2013
SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617FMaya Koren-Michowitz, Sigal Gery, Takayuki Tabayashi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 16, 2018
Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cellsHélène Marijon, Dhong Hyun Lee, LingWen Ding, et al.
Cancer Research|June 3, 2005
CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cellsTakayuki Ikezoe, Sigal Gery, Dong Yin, et al.
Oncotarget|September 10, 2021
Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation statusHélène Marijon, Sigal Gery, Hua Chang, et al.
Experimental Hematology|March 24, 2007
RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiationSigal Gery, Dorothy J Park, Peter T Vuong, et al.
International Journal of Cancer|April 10, 2007
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cellsTakashi Kumagai, Naoki Wakimoto, Dong Yin, et al.
International Journal of Cancer|June 19, 2013
Novel Gemini vitamin D3 analogs: large structure/function analysis and ability to induce antimicrobial peptideRyoko Okamoto, Sigal Gery, Yoshio Kuwayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancerSigal Gery, Naoki Komatsu, Norihiko Kawamata, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Blood|June 30, 2005
Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemiaSigal Gery, Adrian F Gombart, William S Yi, et al.
Blood|August 17, 2004
Retinoic acid regulates C/EBP homologous protein expression (CHOP), which negatively regulates myeloid target genesSigal Gery, Dorothy J Park, Peter T Vuong, et al.
British Journal of Haematology|April 18, 2013
SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617FMaya Koren-Michowitz, Sigal Gery, Takayuki Tabayashi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 16, 2018
Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cellsHélène Marijon, Dhong Hyun Lee, LingWen Ding, et al.
Cancer Research|June 3, 2005
CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cellsTakayuki Ikezoe, Sigal Gery, Dong Yin, et al.
Oncotarget|September 10, 2021
Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation statusHélène Marijon, Sigal Gery, Hua Chang, et al.
Experimental Hematology|March 24, 2007
RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiationSigal Gery, Dorothy J Park, Peter T Vuong, et al.
International Journal of Cancer|April 10, 2007
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cellsTakashi Kumagai, Naoki Wakimoto, Dong Yin, et al.
International Journal of Cancer|June 19, 2013
Novel Gemini vitamin D3 analogs: large structure/function analysis and ability to induce antimicrobial peptideRyoko Okamoto, Sigal Gery, Yoshio Kuwayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancerSigal Gery, Naoki Komatsu, Norihiko Kawamata, et al.
Pageof 6